3Tsueda K, Oliver PB, Richter RW. Cardiovascular manifestations of tetanus [ J]. Anesthesiology, 1974,40 ( 6 ) : 588-592.
4Kubota T, Miyagishima M, Alvarez R J, et al. Expression of proinflammatory cytokines in the failing human heart: comparison of recent - onset and end - stage congestive heart failure[ J]. J Heart Lung Transplant,2000, 19(9) :819-824.
5Brauner JS, Clausell N. Neurohumoral, immunoinflammatory and cardiovascular profile of patients with severe tetanus : a prospective study[J]. J Negat Results Bio Med,2006, 5:2
6Goto T, Fukushima H, Sasaki G, et al. Evaluation of autonomic nervous system function with spectral analysis of heart rate variability in a case of tetanus[ J]. Brain Dev,2001,23 (8) :791-795.
7Ablett JJL. Analyses and main experiences in 82 patients treated in the Leeds Tetanus Unit. In Symposium on tetanus in Great Britain Edited by: Ellis M. Boston[ J]. National Lending Library, 1967,8 (2) : 1-10.
8Cook TM, Protheroe RT, Handel JM. Tetanus: a review of the literature[ J]. Br J Anaesth,2001,87(3) :477-487.
9Miranda - Filho Dde B, Ximenes RA, Barone AA, et al. Randomised controlled trial of tetanus treatment with antitetanus immunoglobulin by the intrathecal or intramuscular route [J].BMJ,2004,328 (7440) :615.
10Kabura L, Ilibagiza D, Menten J, et al. Intrathecal vs. intramuscular administration of human antitetanus immunoglobulin or equine tetanus antitoxin in the treatment of tetanus: a meta - analysis[J]. Trop Med Inter Health,2006,11 (7) :1075-1081.
